Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes

Cellular Immunology

Volumn 285, Issue 1-2, 2013, Pages 6-9

  Białoszewska, Agata ^a,b   Baychelier, Florence ^c,d   Niderla Bielińska, Justyna ^a   Czop, Andrzej ^e   Debré, Patrice ^c,d   Vieillard, Vincent ^c,d   Kieda, Claudine ^b   Malejczyk, Jacek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITÉ D'ORLÉANS   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e Prof Bogdanowicz Memorial Hospital   (Poland)

Author keywords

Articular chondrocytes; Cartilage; NK cells; NKp44 ligand; NKp44 receptor

Indexed keywords

NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2;

ARTICLE; CARTILAGE CELL; CELL MEDIATED CYTOTOXICITY; CELL STIMULATION; CHILD; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MOLECULAR RECOGNITION; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHOOL CHILD; TARGET CELL;

ARTICULAR CHONDROCYTES; CARTILAGE; NK CELLS; NKP44 LIGAND; NKP44 RECEPTOR;

CARTILAGE; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CHONDROCYTES; CLUBFOOT; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INFANT; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2;

EID: 84884176229     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.08.005     Document Type: Article

References (15)

1. Tiku M.L., Liu S., Weaver C.W., Teodorescu M., Skosey J.L. Class II histocompatibility antigen-mediated immunologic function of normal articular chondrocytes. J. Immunol. 1985, 135:2923-2928.
2. Bujia J., Alsalameh S., Sittinger M., Hammer C., Wilmes E., Burmester G. Antigen presenting cell function of class II positive human nasal chondrocytes. Acta Otolaryngol. 1994, 114:75-79.
3. Malejczyk J., Kaminski M.J., Malejczyk M., Majewski S. Natural cell-mediated cytotoxic activity against isolated chondrocytes in the mouse. Clin. Exp. Immunol. 1985, 59:110-116.
4. Malejczyk J., Malejczyk M., Urbanski A., Luger T.A. Production of natural killer cell activity - augmenting factor (interleukin-6) by human epiphyseal chondrocytes. Arthritis Rheum. 1992, 35:706-713.
5. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008, 9:503-510.
6. McQueen K.L., Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 2002, 14:615-621.
7. Chiesa S., Tomasello E., Vivier E., Vely F. Coordination of activating and inhibitory signals in natural killer cells. Mol. Immunol. 2005, 42:477-484.
8. Sommaggio R., Cohnen A., Watzl C., Costa C. Multiple receptors trigger human NK cell-mediated cytotoxicity against porcine chondrocytes. J. Immunol. 2012, 188:2075-2083.
9. Hyc A., Osiecka-Iwan A., Strzelczyk P., Moskalewski S. Effect of IL-1beta, TNF-alpha and IL-4 on complement regulatory protein mRNA expression in human articular chondrocytes. Int. J. Mol. Med. 2003, 11:91-94.
10. Malejczyk J. Natural anti-chondrocyte cytotoxicity of normal human peripheral blood mononuclear cells. Clin. Immunol. Immunopathol. 1989, 50:42-52.
11. Vieillard V., Strominger J.L., Debré P. NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10981-10986.
12. Porgador A. Natural cytotoxicity receptors: pattern recognition and involvement of carbohydrates. Sci. World J. 2005, 5:151-154.
13. Białoszewska A., Niderla-Bielińska J., Hyc A., Osiecka-Iwan A., Radomska-Leśniewska D.M., Kieda C., Malejczyk J. Chondrocyte-specific phenotype confers susceptibility of rat chondrocytes to lysis by NK cells. Cell. Immunol. 2009, 258:197-203.
14. Conigliaro P., Scrivo R., Valesini G., Perricone R. Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. Autoimmun. Rev. 2011, 10:577-581.
15. Yamaga K.M., Bolen H., Kimura L., Lance E.M. Enhanced chondrocyte destruction by lymphokine-activated killer cells. Possible role in rheumatoid arthritis. Arthritis Rheum. 1993, 36:500-513.